Current Events
Friday, January 10, 2020
Dive Brief:
- Mylan has started a voluntary nationwide recall on three lots of a commonly prescribed stomach ulcer drug after finding trace amounts of a probable human carcinogen, the drugmaker stated Wednesday.
- The recall is focused on three batches that were distributed in 2017 and 2018. Testing found low levels of NDMA, or N-nitrosodimethylamine, a likely carcinogen and environmental contaminant. Mylan said it had received no reports of related adverse events.
- The medicine, nizatidine, is approved as a short-term ulcer treatment as well as for the treatment of esophagitis and heartburn from gastroesophageal reflux disease, or GERD.
Read More
Alan W. Clark & Associates represent clients throughout Long Island and the New York Metropolitan Area, including New York County, Richmond County, Kings County, Queens County, Bronx County, Nassau County, Suffolk County, and Westchester County.
Attorney Advertising